RENAISSANCE TECHNOLOGIES LLC
Position in LKFT — Lakefront Biotherapeutics NV
CIK 1037389
NEW YORK, NY
Position in LKFT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,225,844
+$2,763,844 QoQ
Shares Held
407,800
+29.3% QoQ
Ownership
0.623%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#8
of 78 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,951,130,026 across 312 Biotechnology names. LKFT ranks #44 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in LKFT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,225,844 | 407,800 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,462,000 | 315,400 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,156,620 | 310,600 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,338,768 | 356,200 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,006,953 | 464,700 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,309,696 | 330,800 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,142,750 | 296,100 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $8,397,438 | 291,679 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,710,424 | 270,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,581,300 | 266,500 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $10,699,080 | 263,200 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,736,190 | 281,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,519,214 | 307,900 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,848,576 | 358,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $14,928,544 | 336,380 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,732,304 | 298,600 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,855,140 | 248,300 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,240,690 | 84,500 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,120,358 | 56,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,677,849 | 50,900 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $702,678 | 10,200 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $824,863 | 10,700 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,414,591 | 74,910 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $25,543,800 | 180,000 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $51,532,148 | 261,200 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $46,078,816 | 235,192 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||